Evidence map›Paper›PMID 26820065›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2016

Evidence for an association between infant mortality and homozygosity for the arctic variant of carnitine palmitoyltransferase 1A.

Bradford D Gessner, Thalia Wood, Monique A Johnson, Carolyn Sue Richards, David M Koeller

Open access · bronzeAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Association of theFrontiers in pediatrics · 2021
    Article
  7. Article
  8. Review
  9. Health effects of the CPT1A P479L variant: responsible public health policy.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  10. Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Bradford D GessnerAlaska Division of Public Health, Anchorage, Alaska, USA.
Thalia WoodAlaska Division of Public Health, Anchorage, Alaska, USA.ORCID 0000-0001-9563-6391
Monique A JohnsonDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon, USA.
Carolyn Sue RichardsDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0003-1078-979X
David M KoellerDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-4340-4908
Oregon Health & Science University · USAssociation of Public Health Laboratories · US

Funding

Impact of the P479L Variant in CPT1A on Infant Mortality in AlaskaR03HD060728 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI KOELLER, DAVID M · 2010 to 2011
$152k
NICHD NIH HHS R03 HD060728
6 · The paper itself

Abstract

purposeInfant mortality in Alaska is highest among Alaska Native people from western/northern Alaska, a population with a high prevalence of a genetic variant (c.1436C>T; the arctic variant) of carnitine palmitoyltransferase 1A (CPT1A).

methodsWe performed an unmatched case-control study to determine the relationship between the arctic variant and infant mortality. The cases were 110 Alaska Native infant deaths from 2006 to 2010 and the controls were 395 Alaska Native births from the same time period. In addition to the overall analysis, we conducted two subanalyses, one limited to subjects from western/northern Alaska and one limited to infants heterozygous or homozygous for the arctic variant.

resultsAmong western/northern Alaska residents, 66% of cases and 61% of controls were homozygous (adjusted odds ratio (aOR): 2.5; 95% confidence interval (CI): 1.3, 5.0). Among homozygous or heterozygous infants, 58% of cases and 44% of controls were homozygous (aOR: 2.3; 95% CI: 1.3, 4.0). Deaths associated with infection were more likely to be homozygous (OR: 2.9; 95% CI: 1.0-8.0). Homozygosity was strongly associated with a premorbid history of pneumonia, sepsis, or meningitis.

conclusionHomozygosity for the arctic variant is associated with increased risk of infant mortality, which may be mediated in part by an increase in infectious disease risk. Further studies are needed to determine whether the association we report represents a causal association between the CPT1A arctic variant and infectious disease-specific mortality.Genet Med 18 9, 933-939.

Indexed as

Infant MortalityNeonatal ScreeningAlaskaAlaska NativesCarnitine O-PalmitoyltransferaseCommunicable DiseasesFemaleGenetic Association StudiesGenetic VariationHomozygoteHumansIndians, North AmericanInfantInfant, NewbornMaleMeningitisCarnitine O-PalmitoyltransferaseCPT1A protein, human

Identifiers

PMID26820065
PMCPMC4965343
OpenAlexW2388091980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.